Specific Oncolytic Adenovirus Driven by Human A33 Promoter Region for Colorectal Cancer Therapy

被引：0
|
作者：
Cafferata, Eduardo G. [1 ,2 ]
Maccio, Daniela R. [1 ]
Lopez, Maria V. [1 ]
Viale, Diego L. [1 ]
Podhajcer, Osvaldo L. [1 ]
机构：
[1] UBA, CONICET, Leloir Inst, Gene Therapy Lab, Buenos Aires, DF, Argentina
[2] CeNaGeM ANLIS Carlos G Malbran, Expt Genet Dept, Buenos Aires, DF, Argentina
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.713
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
637
引用
收藏
页码：S245 / S245
页数：1
相关论文
共 50 条
  • [41] 124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
    O'Donoghue, Joseph A.
    Smith-Jones, Peter M.
    Humm, John L.
    Ruan, Shutian
    Pryma, Daniel A.
    Jungbluth, Achim A.
    Divgi, Chaitanya R.
    Carrasquillo, Jorge A.
    Pandit-Taskar, Neeta
    Fong, Yuman
    Strong, Vivian E.
    Kemeny, Nancy E.
    Old, Lloyd J.
    Larson, Steven M.
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (12) : 1878 - 1885
  • [42] A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer
    Li, Yan
    Gao, Yuan
    Gong, Chunai
    Wang, Zhuo
    Xia, Qingming
    Gu, Fenfen
    Hu, Chuling
    Zhang, Lijuan
    Guo, Huiling
    Gao, Shen
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (07) : 1973 - 1985
  • [43] Coxsackievirus A11 as a novel oncolytic viral therapy for human colorectal cancer
    Ogata, Hisanobu
    Wang, Beibei
    Miyamoto, Shoei
    Takishima, Yuto
    Sagara, Miyako
    Murahashi, Mutsunori
    Onishi, Hideya
    Tani, Kenzaburo
    CANCER RESEARCH, 2019, 79 (13)
  • [44] A functional polymorphism in the promoter region of IL-33 is associated with the reduced risk of colorectal cancer
    Li, Zhao-Hui
    Han, Bao-Wei
    Zhang, Xie-Fu
    BIOMARKERS IN MEDICINE, 2019, 13 (07) : 567 - 576
  • [45] Oncolytic-adenovirus-expressed RNA interference for cancer therapy
    Pei, Dong-Sheng
    Di, Jie-Hui
    Chen, Fei-Fei
    Zheng, Jun-Nian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (09) : 1331 - 1341
  • [46] Efficacy of an Oncolytic Adenovirus Driven by a Chimeric Promoter and Armed with Decorin Against Renal Cell Carcinoma
    Zhang, Wen
    Zhang, Chen
    Tian, Weiping
    Qin, Jing
    Chen, Jing
    Zhang, Qi
    Fang, Lin
    Zheng, Junnian
    HUMAN GENE THERAPY, 2020, 31 (11-12) : 651 - 663
  • [47] Bioreducible polymer-conjugated hepatoma-specific oncolytic adenovirus for systemic cancer gene therapy
    Yun, Chae-Ok
    Kim, Pyung-Hwan
    Kim, Tae-il
    Yockman, James W.
    Kim, Sung Wan
    HUMAN GENE THERAPY, 2010, 21 (10) : 1405 - 1405
  • [48] Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma
    Liu, Lei
    Wu, Wenbin
    Zhu, Guangze
    Liu, Liming
    Guan, Guofang
    Li, Xiao
    Jin, Ningyi
    Chi, Baorong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 (04) : 747 - 754
  • [49] Oncolytic Adenovirus with SPAG9 shRNA Driven by DD3 Promoter Improved the Efficacy of Docetaxil for Prostate Cancer
    Lu, Meng
    Wei, Fu-kun
    Wu, Chuang
    Xu, Zi-yang
    Mao, Li-jun
    Yang, Dong-rong
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [50] TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection
    Yao, Xinglei
    Yoshioka, Yasuo
    Eto, Yusuke
    Morishige, Tomohiro
    Okada, Yuka
    Mizuguchi, Hiroyuki
    Mukal, Yohei
    Okada, Naoki
    Nakagawa, Shinsaku
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (02) : 419 - 424
12345